
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Grifolan is a beta-glucan polysaccharide extracted from Grifola frondosa (maitake mushroom) that activates immune cells through Toll-like receptor binding. This bioactive compound enhances immune function and demonstrates anti-cancer properties by stimulating macrophages and natural killer cells.

Reported Benefits (Provisional)
Origin & History

Grifolan is a polysaccharide derived from the maitake mushroom, known for its immune-enhancing properties. It has been studied for its potential therapeutic effects.
Research Narrative (Provisional)
Research has demonstrated grifolan's ability to enhance immune response and its potential anti-cancer effects. Studies continue to explore its role in metabolic health and weight management.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains beta-glucans that support immune health. - Low in calories and fat, making it a healthy addition to the diet. - Rich in polysaccharides with health-promoting properties.
Reported Mechanism (Provisional)
Grifolan binds to Toll-like receptors (TLR-2 and TLR-4) and complement receptor 3 (CR3) on immune cells, triggering downstream signaling cascades. This binding activates macrophages, dendritic cells, and natural killer cells, leading to increased cytokine production including interleukin-1β, tumor necrosis factor-α, and interferon-γ. The compound also enhances phagocytic activity and promotes T-helper cell differentiation toward Th1 responses.
Clinical Narrative (Provisional)
Human studies on grifolan are limited, with most evidence coming from in vitro and animal research. A small pilot study (n=36) showed 30% increased immune cell activity after 4 weeks of supplementation. Animal studies demonstrate 25% tumor growth reduction in cancer models, but human cancer trials are lacking. The evidence suggests immune-enhancing properties, though larger randomized controlled trials are needed to confirm clinical efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







